chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Horrible feeling; Blood pressure goes high; Joint hurt; Fever/ very low temperature; This is a spontaneous report from a contactable consumer via Pfizer-sponsored program. A 77-years-old female consumer (patient) reported for herself that she received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number was not reported) via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunization. The patient previously took tylenol as per her common sense and epipens (double dose) for swollen mouth and lips (due to a cleaner) two months ago. Concomitant medications were not reported. As per the description, it was reported that the patient was scared because she didn't had anyone. She was hesitated to get a vaccine. She experienced some reactions after her 2nd dose of the Pfizer vaccine. Her joint hurt and she was in a bad situation. She had a very low temperature than the normal temperature, blood pressure was high when she got upset. She was very angry that she had fever and had nobody to ask a question. She reported that no one told her about a high fever (100.4) or to go to the hospital. She said it was not worth it for her to get a fever. She reported the information on the paper was very vague and not clear, she felt horrible as she suffered and wanted to let know. She wanted to complain that the temperature of fever was not written and none of those were approved. She was asked to contact her local doctor. That was the most horrible experience for her. The patient underwent lab tests and procedures which included blood pressure measurement as high, body temperature as and 100.4. The outcome of all the events was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Heart palpitations, dizziness, chest pains, shortness of breath while at rest. Odd feeling of fullness in left chest. Same pattern as last booster shot. Moderate work would leave me light headed and very winded. Grew worse over the next 50 days. Currently wearing a heart monitor for the last two weeks. Scheduled for a heart stress test tomorrow, 3/11/2022.
Day 10. Varicella type truncal rash-mostly papular some papulovesicles-same as face a few in inguinal area.
Developed a local reaction to the injection site about the size of a silver dollar, after about a week it grew in size  and developed a rash on the back of the arm . Rash was raised and itchy took Benadyl for 2 weeks for relief.
This case was reported by a consumer via call center representative and described the occurrence of shoulder pain in a 36-year-old female patient who received SHINGRIX for prophylaxis. The patient's past medical history included shoulder pain (already had that shoulder injured before). In February 2019, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a month after receiving SHINGRIX, the patient experienced shoulder pain, condition aggravated and injection site pain. On an unknown date, the outcome of the shoulder pain, condition aggravated and injection site pain were unknown. It was unknown if the reporter considered the shoulder pain, condition aggravated and injection site pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported, but the patient was 36 years old at the time of reporting. The patient received SHINGRIX in the shoulder, above the deltoid (unknown deltoid). The patient was hoping for the best, but It hurt so bad that she hardly was able to sleep due to the pain. The patient already had shoulder injured before receiving vaccine and so it got aggravated. The patient asked for any suggestions.
8/30/2023 - 9/1/2023 (2 days) Date of Admission: 8/30/2023  Discharge Date: September 1, 2023 Discharge Disposition: SNF Presented to the hospital with shortness of breath. Tested positive for COVID-19 in the outpatient setting. Did not meet criteria for remdesivir or Decadron as he was not hypoxemic. Was placed on prednisone for steroid therapy and discharged on a 5 day burst to complete his steroid therapy.  6/23/2022 Moderna 004M21A 11/1/2021 Moderna 012F21A 1/30/2021 Moderna 012M20A 1/2/2021 Moderna 011L20A 10/18/2022 Moderna Bivalent 061F22A
EXACERBATED SARCOIDOSIS SYMPTOMS; This spontaneous report received from a patient via a company representative via social media (J and J Corporate) concerned a patient of unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: sarcoidosis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number and expiry were not reported) dose, start therapy date were not reported, 1 total, administered for covid-19 prophylaxis. The batch number was not reported. Per procedure no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced exacerbated sarcoidosis symptoms and had hard enough time fighting the horrible rare disease for which no one knows how to treat. It was reported that "I just read where the COVID vac may have caused some people to have Sarcoidosis and or at least exacerbated my symptoms. I'm having a hard enough time fighting this horrible rare disease that no one knows how to treat, let alone the fact if I get the booster I can have a flare. No more for me". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from exacerbated sarcoidosis symptoms. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20221257157.; Sender's Comments: V0: 20221257169-exacerbated sarcoidosis symptoms. The event has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event. Specifically: MEDICAL HISTORY. Therefore, this event is considered inconsistent with vaccine administration.
pt recv vax 9OCT95 & devel warmth & a pink area around the inj site;no tx necessary;pt recovered;
Information has been received from a registered nurse concerning a female patient between the ages of 11 to 13 who within the last 3 months was vaccinated intramuscularly with a 0.5 mL dose of HPV. Subsequently the patient experienced dizziness to the point of losing consciousness. The event lasted for a matter of seconds. The patient was well enough to leave in a few minutes. Additional information has been requested.
patient reported to the pharmacy that they had to go to ER for blood clot on 04/19/2021
Received Moderna 1st dose on 3/8. On March 14th the injection site itched like crazy, then the area swelled, becoming red, hard, and hot. Her symptoms have not resolved at this time.
69 year old female patient came into get PNEUMOVAX 23 at the pharmacy on 8/18/20, but informed pharmacist today 8/19/20 that she received the same vaccine at the doctor's office 6 months ago.; This spontaneous report was received from a pharmacist and refers to a 69-year-old female patient. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On an unknown date in approximately February 2020 (reported as 6 months ago), the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (exact dose, injection site, route of administration, lot # and expiration date were not provided) for prophylaxis. On 18-AUG-2020, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection in prefilled-syringe, lot # T009744, expiration date was reported as January 2020, but upon internal verification was established as 28-JAN-2022 (exact dose, injection site and route of administration were not provided). On the next day, the patient informed the pharmacist that she received the same vaccine at the doctor's office 6 months ago. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp; manufactureraddress: manufacturercity: manufacturerstate:  manufacturercountry: devicelotnumber: T009744; expirationdate: 28-JAN-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
administered the adjuvant onlywithout reconstituting the vaccine; Only adjuvant administered; This case was reported by a physician via sales rep and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 14-Feb-2023 Reporter's Comments: A physician stated in his office one day before the reporting date that a nurse that no longer worked at the practice, administered the Shingrix adjuvant only, without reconstituting the vaccine, to 3 different patients in the physician's office.  The reporter did not have any further information about this incident, nor any information about lot number, date this happened or any differing factors for any of the 3 patients.  The reporter told to the GlaxoSmithKline field representative that the physician's office did contact the 3 patients, and it had all been taken care of.  The reporter consented to follow up with health care professional was obtained.  Additional supportive information: The patient received only adjuvant of Shingrix vaccine, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. This 3 of 3 linked cases reported by same reporter for different patients.; Sender's Comments:  US-GSK-US2023AMR026705:Same reporter US-GSK-US2023025414:Same reporter
3-28-11 11:30 am: about 5 x 5 1/2 in. pink, raised, warm area of erythema to left lateral thigh, tx with diphenhydramine p.o. & hcz crm topically. 3-30-11 9:00 am: swelling has decreased per pt's mom.
itchy arms; This is a Spontaneous report from a contactable consumer. A male patient of unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on unspecified date as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On unspecified date, the patient experienced itchy arms. The outcome of the event was unknown.  No Follow-up attempts are needed. Information about lot/batch cannot be obtained.
regarding a patient who had Shingles after receiving the Pfizer Covid-19; This is a spontaneous report received from a contactable consumer or other non hcp.A patient of unspecified age and gender received bnt162b2(Pfizer Covid 19-Vaccine,Batch/Lot number was not reported)via an unspecified route of administration on an unspecified date, as Dose number unknown,single for covid-19 immunization.The patient medical history and concomitant medications were not reported.The patient experienced regarding a patient who had shingles after receiving the pfizer covid-19 on an unspecified date.Patient's information and gender was not written on the questionnaire/form. Unable to ask if the caller is HCP. Unable to transfer, the caller hung up while talking to the representative.The patient received no treatment for the event.The outcome of the events was unknown. The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Arm injection site feels warm to touch; Arm injection site feels inflamed; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE WARMTH (Arm injection site feels warm to touch) and VACCINATION SITE INFLAMMATION (Arm injection site feels inflamed) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Nov-2021, the patient experienced VACCINATION SITE WARMTH (Arm injection site feels warm to touch) and VACCINATION SITE INFLAMMATION (Arm injection site feels inflamed). At the time of the report, VACCINATION SITE WARMTH (Arm injection site feels warm to touch) and VACCINATION SITE INFLAMMATION (Arm injection site feels inflamed) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment details not provided.
Sever two day migraine starting the day after injection, fever, chills, myalgia in lower back
Suspected vaccination failure; shingles, got them anyway, horrible; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 19-APR-2022 Reporter's comment: This case was reported by a patient via interactive digital media. The patient had the shingles shot and got shingles anyway.  The patient stated shingles were horrible.  Additional supportive information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Patient admitted to hospital for rule out sepsis after presenting to the E.D. with temperature of 102.5F.
Redness and pain-- radiating to severe local reaction.  MD diagnosed as an infection and is treating her with Cephalexin 500mg one capsule three times a day.
Patient admitted 9/11/2022 with NSTEMI, Nausea/vomiting, weakness, coughing, SOB
Janssen COVID-19 Vaccine EUA About 8 hours after the injection, I started having strong chills.  About 10 hours  after, I started having an incredibly fast heartbeat that lasted for about 10 hours. I tried some breathing exercises to bring it down, but that did not work.  I did not seek medical care as it went back to normal throughout the morning of the following day.  But kind of scary.  Also had a low temperature of 98 on the scanner thermometer.  Normal is 96 something.
Severe raised burning itching rash, severe headache, vision blurred, very tired fatigue, joint muscle pain, throat pain, mental fog slowness,severe pain at surgery site, increased tremor, pain in chest, itching keeps waking me up
Three hours post 2nd dose of Havrix, Client collapsed at home, BP decreased 60/45 with decreased HR. Client admitted to hospital . Tested for"everythjng" according to client partner. Client doing well now, at home, no diagnosis given for  events.
FLUAD: PATIENT EXPERIENCED LOW GRADE FEVER, 100.4, AND UNABLE TO RAISE LEFT ARM
Saturday night I felt sick. The next day my ears and throat were extremely sore for about 6 days. I was then fatigue for about a week. I continued to be tired for another few days. I had a telehealth appointment.
Pt reported "quarter-inch diameter" red hot spot at injection site that began shortly after injection. Hives on torso beginning last night and spreading this AM to both arms. Denied SOB, difficulty swallowing or h/o adverse reactions to vaccinations as a child. Pt advised to take 50mg Benadryl and call if no improvement or go to local clinic if s/s anaphylaxis.
EMS assessed and Medical Greeter spoke with client. Client was recommended to bring companion for second dose. Client will take car/taxi/uber home. Cleared by EMS and denied needing further EMS services to hospital.
Fever to 102.2, On Tylenol, Redness with increased warmth, induration, Left deltoid area associated tenderness also left axillary, lymph glands
Pt had a large site reaction about 1 week post injection. Skin was red, raised, itchy and warm to the touch. Approx. size 10 x 20 cm.
Had the vaccine October 22 in my left arm. That day, the site stayed swollen and painful. The next day, October 23rd, I was feeling weak, temperature 102.4, chills and generalized malaise. The fever lasted 2 days. The injection site was getting more swollen, painful and reddened for more than a week. I had a skin reaction in the side of my right calf simultaneously as my arm was having the reaction. I did show my calf to a doctor and a nurse practitioner at work. I was also coughing a lot. I went back to the doctor on November 1st since my arm was still swollen, itchy and painful. Dr ordered prednisone and BACTRIM. As I was taking the medications for allergies, I developed breathing symptoms, lots of wheezes rhonchi which forced me to go to the doctor again. The skin of the injection site is presently peeling off. Please follow up on my complaints to get the manufacturer and lot number for the vaccine that I was given. Thanks.
1-2 wks after second Pfizer shot I began feeling heart symptoms : gurling, fluttering. I tried to ignore it but it peaked in June (20 times in one hour) and I went to Urgent Care for EKG.  Dr said this activity did not appear life threatening but to followup with cardiologist for holter monitor, etc.   I have appt pending.  Not sure if they'll find some damage left by the situation.  The symptoms eventually settled down.  I did not make the immediate connection to vaccine but in hindsight it seems obvious.
Arm pain started after injection and worsened for 12 hours but started improving (still present at 2.5 days later); total body aches started 12 hours post injection and significant for 12 hours; severe chills (no fever) started 17 hours post injection and continued for 12 hours; sweats and feeling hot (no fever) started 40 hours post injection and continued for 12 hours.  Erythematous rash circling arm at level of injection site noticed 48 hours post injection but unclear when appeared.
dose was given after expiration date; dose was given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose was given after expiration date) and PRODUCT STORAGE ERROR (dose was given after expiration date) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose was given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (dose was given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (dose was given after expiration date) and PRODUCT STORAGE ERROR (dose was given after expiration date) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information provided.  The patient received Unk 3rd or Booster dose.  The vial did not undergo any temperature excursion.  Date of vaccine placed in refrigerator was 29-Oct-2021  Patient did not experience any adverse event.  No treatment information provided.
Moderna COVID-19 Vaccine EUA Date of first dose: 2/11/2021; Date of second dose: 3/11/2021 A couple weeks after second dose I noticed side effects of no sense of taste or smell. This continues today, 5/25/2021. Visited my medical professional, APR, CNP, for my symptoms on 5/21/2021.
Appeared with redness, warmth - arms, neck, chest, around mouth, swelling noted to right ear = angioedema. No SOB.
Aprox 4 hours after receiving vaccine injection it became difficult to swallow - then developed dyspnea and wheezing. Received ALBUTEROL neb x 2 - BENADRYL 50 mg and SOLUMEDROL 250 mg and Epi 0.5 mg subcut in ER.
Approx 4AM 6/19/21 is when I noticed I was experiencing vaginal bleeding beyond what I had ever experienced before. I was not due for a menstrual cycle. Between 4AM and 10AM I went through 3 overnight sanitary pads. Over the course of the rest of the day I went through 8 regular pads, soaking them through with blood. I contemplated going to the ER. The blood was excessive and bright red, freely flowing and passing clots larger than a dollar coin. The bleeding finally slowed around 36hr after it began. I used ibuprofen beginning the evening of 6/19/21 to help stop the bleeding. The bleeding finally stopped entirely the evening of 6/21/21. The most unique part is that there was little to no pain, even before I began to take the ibuprofen.
Reaction to #4 DTAP, 8 cm x 6 cm, erythematous macular rash at injection site.
Within 1 minute of receiving Menactra inj, became pale, slid to floor out of chair. RN lowered to floor. Stiffened body for approx 15-30 secs, face reddened, woke up w/arms flailing, given O2 via mask at 2L approx 3 mins, BP 120/78 lying. Oriented x3.  Remained lying on floor approx 10 mins, then up in chair 20 mins, Alert and talking appropriately.  Walked to class unassisted.
Client received the 1st dose of Pfizer COVID vaccine lot # EW0179 and expiration date 5/10/21 at 2:44pm.  Client reports to vaccinator, that he feels dizzy.  PHN walked over to assist. Client reports no medical history except COVID positive in December with mild symptoms.  Client reports his last meal was breakfast. RN offered client water. Vital signs taken at 2:44pm blood pressure: 130/70, oxygen:100% and pulse: 69.  Client reports he is also feeling tired. Client denies any other symptoms.  At 2:51pm vitals were taken. Blood pressure: 125/70, oxygen: 99% and pulse 68. Client reports symptoms dizziness slightly improved. At 2:54pm client reports he is tired and has mild dizziness. Vitals are blood pressure:120/65, oxygen:99% and pulse:64.  At 2:59pm client reports having cold hands and PHN  called PHN to come evaluate client.  Another set of vitals was taken blood pressure: 115/68, oxygen: 99% and pulse: 68.  PHN educated client on worsening signs and symptoms and when to call EMS. Client verbalized understanding of education. Client reports he is getting a ride home by his sister. Client left facility unassisted with a steady gait at 3:20pm.